Outcome | Control | Within-group differences | Intervention | Within-group differences | Between-groups differences | No. subjects | ||
---|---|---|---|---|---|---|---|---|
Median (ranges) | (95% CI) | P value | Median (ranges) | (95% CI) | P value | P value | Control/Intervention | |
Swallowing ratea | ||||||||
Baseline | 5.1 (0.0–9.5) | 5.3 (0.0–9.2) | 20/20 | |||||
End of treatment (5 weeks) | 9.2 (1.8–13.4) | 3.6 (1.0–5.8) | 0.001b | 10.3 (3.2–18.7) | 5.3 (2.2–8.6) | < 0.001b | 0.133c | 14/18 |
12 months post-treatment | 8.5 (2.9–10.5) | 1.1 (−1.0–6.6) | 0.164b | 13.7 (5.0–28.3) | 9.0 (3.7–13.6) | 0.008b | 0.032c | 9/9 |
Lip force | ||||||||
Baseline | 14.0 (3.0–31.0) | 18.5 (7.0–34.0) | 14/18 | |||||
End-of-treatment (5 weeks) | 14.0 (6.0–46.0) | 2 (−1–10) | 0.079 | 27.0 (11.0–59.0) | 7 (3–13) | < 0.001 | 0.066 | 14/18 |
12 months post-treatment | 10.0 (2.0–21.0) | −1 (−3–1) | 0.328 | 31.0 (18.0–51.0) | 12 (4–26) | 0.008 | 0.001 | 9/9 |
VFS (PAS score) | ||||||||
Baseline | 6 (1–8) | 3 (1–8) | 13/18 | |||||
End of treatment (5 weeks) | 1 (1–8) | 0.0 (−6–6) | 0.524b | 2 (1–8) | 0.0 (−2–0) | 0.219b | 0.999 | 11/18 |
12 months post-treatment | 1.5 (1–8) | 0.0 (−7–6) | 0.276b | 2 (1–8) | −0.5 (−3–0) | 0.058b | 0.912 | 8/9 |